Lv72
4658 积分 2021-10-09 加入
Exploring the next generation of antibody–drug conjugates
3天前
已完结
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
4天前
已完结
Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non–Small Cell Lung Cancer
6天前
已完结
The Far Side of Resistance to RAS Inhibitors
7天前
已完结
297 (PB285): Preclinical Evaluation of RMC-7977, a Multi-Selective RAS(ON) Inhibitor, as a Therapeutic Strategy for KRAS-Mutant Cholangiocarcinoma
11天前
已关闭
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer
11天前
已完结
Overview on Thioredoxin-Interacting Protein (TXNIP): A Potential Target for Diabetes Intervention
26天前
已完结
Thioredoxin‐interacting protein deficiency induces Akt/Bcl‐xL signaling and pancreatic beta‐cell mass and protects against diabetes
29天前
已完结
A small-molecule PI3Kα activator for cardioprotection and neuroregeneration
30天前
已完结
Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations
1个月前
已完结
皖公网安备34019202002308
